Diaceutics (DXRX) Stock Chart & Stock Price History GBX 143 +3.00 (+2.14%) As of 09/5/2025 12:26 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock Diaceutics Stock Price Performance The Diaceutics (DXRX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 13.49%, with a year-to-date return of 16.26%. In the past month, the stock has increased 2.14%, reflecting recent market activity. As of the latest close, Diaceutics traded at GBX 143 with a market cap of £120.90 million and volume of 137,358 shares. Five years ago, the stock traded at GBX 175, representing a 18.29% decrease over that period. At the time, it had a market cap of £147.12 million and a volume of 15,205 shares. Receive DXRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Diaceutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+0.70%1 Month Performance+2.14%3 Month Performance+10.00%Year-To-Date Performance+16.26%1 Year Performance+13.49%5 Year Performance-18.29% DXRX Stock Chart for Sunday, September, 7, 2025 DXRX Chart by TradingView Diaceutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/05/2025GBX 142GBX 143+0.70%GBX 145GBX 138137,358 shs£120.90 million09/04/2025GBX 142GBX 142GBX 142GBX 14085,722 shs£120.06 million09/03/2025GBX 142GBX 142GBX 142GBX 140.1384,904 shs£120.06 million09/02/2025GBX 140.50GBX 142+1.07%GBX 142GBX 140115,345 shs£120.06 million09/01/2025GBX 137.50GBX 140.50+2.18%GBX 142GBX 136127,078 shs£118.79 million08/29/2025GBX 139.50GBX 137.50-1.43%GBX 140GBX 135203,862 shs£116.04 million08/28/2025GBX 137.50GBX 139.50+1.45%GBX 139.85GBX 135.50100,023 shs£117.73 million08/27/2025GBX 137.50GBX 137.50GBX 139.50GBX 13788,119 shs£116.04 million08/26/2025GBX 137.30GBX 137.50+0.15%GBX 140GBX 1357,236 shs£116.04 million08/25/2025GBX 137.30GBX 137.30GBX 137.50GBX 137.30407,505 shs£115.87 million Get the Latest News and Ratings for DXRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Diaceutics and its competitors with MarketBeat's FREE daily newsletter. 08/22/2025GBX 135GBX 137.30+1.70%GBX 137.50GBX 137.30407,505 shs£115.87 million08/21/2025GBX 137.50GBX 135-1.82%GBX 140GBX 135953 shs£113.93 million08/20/2025GBX 137.50GBX 137.50GBX 140GBX 135294,669 shs£116.04 million08/19/2025GBX 138GBX 137.50-0.36%GBX 139GBX 135271,464 shs£116.04 million08/18/2025GBX 139.40GBX 138-1.00%GBX 140GBX 135143,324 shs£116.46 million08/15/2025GBX 137.58GBX 139.40+1.32%GBX 140GBX 13579,038 shs£117.65 million08/14/2025GBX 140GBX 137.58-1.73%GBX 140GBX 135732,865 shs£116.11 million08/13/2025GBX 137.50GBX 140+1.82%GBX 140GBX 135361,589 shs£118.15 million08/12/2025GBX 140GBX 137.50-1.79%GBX 139.90GBX 136.80680,150 shs£116.04 million08/11/2025GBX 137.50GBX 140+1.82%GBX 140GBX 137.25360,171 shs£118.15 million08/08/2025GBX 140GBX 137.50-1.79%GBX 137.70GBX 137.10334,198 shs£116.04 million08/07/2025GBX 136.11GBX 140+2.86%GBX 140GBX 135120,680 shs£118.15 million08/06/2025GBX 138.90GBX 136.11-2.01%GBX 140GBX 135112,712 shs£114.87 million Related Companies Integrated Diagnostics Stock Chart ANGLE Stock Chart Abingdon Health Stock Chart Proteome Sciences Stock Chart Verici Dx Stock Chart GENinCode Stock Chart genedrive Stock Chart LungLife AI Stock Chart LLA.L,0P0001T9GN,0 Stock Chart Advanced Medical Solutions Group Stock Chart Receive DXRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Diaceutics and its competitors with MarketBeat's FREE daily newsletter. This page (LON:DXRX) was last updated on 9/7/2025 by MarketBeat.com Staff From Our PartnersTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredOne tiny company just cracked Google’s $19B problemFor decades, this “AI metal” was trapped in labs, too slow and expensive to ever reach mass production. The...True Market Insiders | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A Millionaire With SEVEN Clicks? $1,000 in just seven stocks in 2004 could have turned into a million-dolla...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Diaceutics PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Diaceutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
